For example, HLA-B*46:01 has low predicted binding to peptides of SARS-CoV-2, suggesting that individuals expressing this molecule may be more vulnerable to COVID-1916, corroborating previous results showing HLA-B*46:01 association with SARS risk12. Here, HLA-B is linked to severe acute respiratory syndrome.